SHARE
COPY LINK

HEALTH

Switzerland likely to tighten coronavirus measures to ‘save summer’: reports

Swiss health officials are set to push for a tightening of coronavirus measures at a meeting between federal and cantonal authorities on Friday, February 19th, Swiss media reports.

Switzerland likely to tighten coronavirus measures to 'save summer': reports
Photo: MARCO BERTORELLO / AFP

Despite falling case numbers, Swiss Health Minister Alain Berset is set to push for a stricter set of coronavirus measures – as well as an extension beyond February 28th – when federal authorities meet with their cantonal counterparts on Friday. 

The major reason is the prevalence of the coronavirus mutation in Switzerland, which Berset fears has the possibility to continue to surge in the coming months. 

Swiss authorities expect the coronavirus mutations to replace the known examples of coronavirus by March to become the dominant strains. 

A source told the NZZ newspaper that Berset is concerned that without urgent action, “there will be very high numbers of infections in May, June and July”. 

By adopting harsher measures now, Switzerland can expect fewer measures to carry through to the summer. 

At the very minimum, Switzerland is expected to extend the existing coronavirus measures beyond their current expiration date of February 28th. 

What is expected to be tightened?

Other than the continuation of the current measures, a range of tightenings are being considered to curb the spread of the mutation. 

Top cantonal doctor Rudolf Hauri, a leading voice in the lockdown efforts, has flagged a number of areas which could be tightened. 

“The situation remains difficult because the activity of the coronavirus mutations is increasing despite drastic measures,” Hauri told the Tages Anzeiger

Hauri pointed to the closure of schools and ski areas as a possible and realistic way the government could curb the spread of the mutation. 

Schools have been shuttered for months in neighbouring Germany, while ski fields in many European countries have not been allowed to open this winter. 

In addition, Hauri flagged the closure of shops other than grocery stores as a possible way of curbing infections. 

Stay at home orders, compulsory FFP2 masks, further contact restrictions, stricter working from home requirements and other measures are being considered. 

Neighbouring Austria put in place a 24-hour stay at home order in December which stayed in place until early February. 

“It comes down to the fact that further efforts are necessary,” Hauri said. 

Will anything be relaxed? 

Whether Berset will be able to get the measures approved by the Federal Council remains to be seen, given the resistance from other parties. 

The FDP's Marcel Dobler said given that infection rates were currently falling “tightening is unacceptable”. 

A government source told the NZZ that the announcement is expected to be accompanied by “a little bit of sugar”, i.e. symbolic relaxations that make the extensions and tightenings a little easier to take. 

Non-essential shops, cultural facilities along with sports will see gradual relaxations. 

Bars and restaurants would not be allowed to open until a second step in the relaxations – with smaller events being again possible in the third round of relaxations. 

A complete relaxation of measures is only expected when a majority of Swiss have been vaccinated. Switzerland wants to vaccinate 5.5 million people – or around 75 percent of the population – by June. 

Testing is expected to be expanded across the country as a way of isolating clusters. Several cantons including Aargau, Graubünden, Vaud, Zug and Basel Country have begun or announced some form of mass testing in recent days. 

 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.
For members

HEALTH

Which medications in Switzerland are set to become more expensive?

The cost of medications in Switzerland is already quite a bit higher than elsewhere in Europe. And now certain drugs will become even pricier.

Which medications in Switzerland are set to become more expensive?

Swiss consumers pay significantly more for their medicines than those in neighbouring European countries. 

This is what emerges from various data published over the years.

“In Switzerland, we pay far too much for medicines compared to abroad,” Matthias Müller, a spokesperson for SantéSuisse, an umbrella group for Swiss health insurance providers, told Swiss media in 2023. 

Even the price of many generic medicines is twice as high in Switzerland as in nine EU countries.

For instance, generics are on average 48 percent cheaper in Belgium, Denmark, Germany, Finland, France, Great Britain, the Netherlands, Austria and Sweden than in Switzerland, according to a price comparison.

And prices for a number of commonly-used drugs will rise even further in the near future.

Why is that?

The Federal Office of Public Health (FOPH) is adapting a new model for calculating the distribution margin. 

A distribution margin is the difference between the distributor’s cost of acquiring goods and the price at which those goods are sold.

From July 1st, 2024, inexpensive medicines whose factory price is less than, or equal to, 15 francs will become more expensive.

This change will affect more than half of medications currently being sold in Switzerland.

As a result of this move, “additional costs of several hundred million will be passed on to patients,” according to Intergenrika, which represents generic drug manufacturers in Switzerland. 

In a nutshell, consumers will pay slightly lower prices for medicines that were previously more expensive, but will also end up paying more  for those that are currently cheaper – like generics.

Which meds will become more expensive?

Pain medications are among those set to become pricier.

One of them is ibuprofen, a popular anti-inflammatory.

While a box of 20 400-mg tablets today costs 5.92 francs, its price will practically double to 11 francs from July 1st.

Though its manufacturing cost will remain the same as today – 1.58 francs – the distribution margin will increase from 4.19 to 9.09 francs.

The same goes for another often-used pain medication, Ponstan.

Ten 500-mg tablets will cost 11.21 francs instead of 6.19 currently.

The manufacturer will continue to charge 1.82 francs for the drug, but the distribution margin will increase from 4.22 to 9.11 francs.

And even generic drugs, which are cheaper – and often by much – will get pricier, at consumers’ expense.

Will some drugs be cheaper?

Yes, some will become slightly less expensive.

One example is the anticoagulant Rivaroxaban whose price will drop from 281 to 267 francs.

READ ALSO: Why you will pay more for certain drugs in Switzerland 2024?

SHOW COMMENTS